News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

“Good But why did it take so long?”

1 October 2008

RMI Media Release

“Good But why did it take so long?”

“While it is good that PHARMAC have announced today that they will begin funding treatments for two types of prostate disease it is shameful that it has taken 15 years in the case of finasteride and seven years for bicalutamide” says RMI Chairman, Dr Pippa MacKay.

“The questions we should be asking is ‘why has it taken so long’ and ‘how many New Zealand men have died or suffered needless pain waiting’.

Bicalutamide will be funded from 1st October for the treatment of advanced prostate cancer and finasteride for the treatment of benign prostatic hyperplasia (enlarged prostate).

“PHARMAC’s medical director Dr Peter Moodie emphasises the point that both of these drugs are off-patent and have been sourced at very competitive prices. This statement exposes the basic problem of PHARMAC’s fixation on cost containment and successive Government’s lack of adequate investment in medicines to meet the health needs of New Zealanders said Pippa MacKay

Finasteride was first registered in New Zealand back in 1993 and bicalutamide which was registered in New Zealand in 2001 has been saving or prolonging the lives of men with prostate cancer since it was launched globally back in 1995.

PHARMAC in its media statement confirm that prostate cancer is the most commonly diagnosed cancer in New Zealand men and the third most common cause of male cancer deaths.

“We urge the incoming Government following the November general election to redress the lack of investment in medicines relative to other OECD countries said Dr Pippa MacKay.


ENDS

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Kakī: World’s Rarest Wading Bird Released In Mackenzie Basin

Conservation Minister Maggie Barry says the birds will add to the 60 released into the Tasman valley earlier this month, significantly boosting the wild population. More>>

ALSO:

IHC Tribute: Colin Meads

"While Colin is best known for rugby, to us he is one of a small number of distinguished IHC New Zealand Life Members recognised for their significant support for people with intellectual disabilities," says IHC Chief Executive Ralph Jones. More>>

ALSO:

Howard Davis Review: Tilting at Turbines - The Trip to Spain

Steve Coogan and Rob Brydon have now both broken the Big Fifty barrier, which seems to have brought a whole new level of angst to their midlife adventures ... More>>

Review: A Rose By Any Other Name Would Smell As Sweet

The Royal New Zealand Ballet has accepted the challenge of this heart-touching tragedy and largely succeeded. More>>

ALSO:

NZ's First Male IAAF Gold: Tom Walsh's Historic Shot Put Victory

Although feeling very sore but with a great feeling Tom Walsh took his place as number one on the victory dais to receive his much deserved gold medal. More>>

ALSO:

Scoop Review Of Books: Q&A: Hard To Find Books

"Unfortunately we are in crisis and this friendly dinosaur faces extinction… Our only hope is to try and raise funds to buy the building and restore it to its glory, either fully funded or with a viable deposit." More>>

 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland